These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7989489)

  • 1. No evidence of mutations in the genes for type I and type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in nonclassical 3 beta HSD deficiency.
    Zerah M; Rhéaume E; Mani P; Schram P; Simard J; Labrie F; New MI
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1811-7. PubMed ID: 7989489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No genetic mutation in type II 3 beta-hydroxysteroid dehydrogenase gene in patients with biochemical evidence of enzyme deficiency.
    Tajima T; Nishi Y; Takase A; Nakae J; Murashita M; Fujieda K
    Horm Res; 1997; 47(2):49-53. PubMed ID: 9030967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Mébarki F; Sanchez R; Rhéaume E; Laflamme N; Simard J; Forest MG; Bey-Omar F; David M; Labrie F; Morel Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2127-34. PubMed ID: 7608265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.
    Simard J; Ricketts ML; Gingras S; Soucy P; Feltus FA; Melner MH
    Endocr Rev; 2005 Jun; 26(4):525-82. PubMed ID: 15632317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
    Sanchez R; Rhéaume E; Laflamme N; Rosenfield RL; Labrie F; Simard J
    J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U
    Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
    Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new inherited variant of the 3 beta-hydroxysteroid dehydrogenase-isomerase deficiency syndrome: evidence for the existence of two isoenzymes.
    Cravioto MD; Ulloa-Aguirre A; Bermudez JA; Herrera J; Lisker R; Mendez JP; Perez-Palacios G
    J Clin Endocrinol Metab; 1986 Aug; 63(2):360-7. PubMed ID: 3088022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family.
    Simard J; Sanchez R; Durocher F; Rhéaume E; Turgeon C; Labrie Y; Luu-The V; Mebarki F; Morel Y; de Launoit Y
    J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):489-505. PubMed ID: 8547174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E; Sanchez R; Simard J; Chang YT; Wang J; Pang S; Labrie F
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.
    Rhéaume E; Lachance Y; Zhao HF; Breton N; Dumont M; de Launoit Y; Trudel C; Luu-The V; Simard J; Labrie F
    Mol Endocrinol; 1991 Aug; 5(8):1147-57. PubMed ID: 1944309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H; Zhang L; Yang X; Chang YT; Kappy M; Slover RS; Jorgensen V; Pang S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase expression and activity in the hypophysectomized rat ovary: interactions between the stimulatory effect of human chorionic gonadotropin and the luteolytic effect of prolactin.
    Martel C; Labrie C; Dupont E; Couet J; Trudel C; Rheaume E; Simard J; Luu-The V; Pelletier G; Labrie F
    Endocrinology; 1990 Dec; 127(6):2726-37. PubMed ID: 1701125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgenic 17 beta-hydroxysteroid dehydrogenase activity of expressed rat type I 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase.
    de Launoit Y; Simard J; Durocher F; Labrie F
    Endocrinology; 1992 Jan; 130(1):553-5. PubMed ID: 1309351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of adrenal 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase expression and activity by adrenocorticotropin and corticosterone in the rat.
    Trudel C; Couët J; Martel C; Labrie C; Labrie F
    Endocrinology; 1991 Oct; 129(4):2077-84. PubMed ID: 1655393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5----4-isomerase expression by adrenocorticotropin in bovine adrenocortical cells.
    Naville D; Rainey WE; Milewich L; Mason JI
    Endocrinology; 1991 Jan; 128(1):139-45. PubMed ID: 1846095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of 3-ketosteroid reductase messenger ribonucleic acid levels and 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase activity in rat liver by sex steroids and pituitary hormones.
    Couet J; Simard J; Martel C; Trudel C; Labrie Y; Labrie F
    Endocrinology; 1992 Dec; 131(6):3034-44. PubMed ID: 1446638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genes encoding gonadal and nongonadal forms of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase are closely linked on mouse chromosome 3.
    Bain PA; Meisler MH; Taylor BA; Payne AH
    Genomics; 1993 Apr; 16(1):219-23. PubMed ID: 8486361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.